Dr. Reddy's Laboratories Limited
RDY
$12.70
-$0.21-1.63%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.40% | 4.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.40% | 4.05% | |||
| Cost of Revenue | 5.72% | 6.18% | |||
| Gross Profit | 1.83% | 2.65% | |||
| SG&A Expenses | 3.95% | 0.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 22.85% | -21.79% | |||
| Total Operating Expenses | 3.57% | 5.18% | |||
| Operating Income | 2.81% | 0.32% | |||
| Income Before Tax | -3.03% | 1.42% | |||
| Income Tax Expenses | -18.90% | 16.88% | |||
| Earnings from Continuing Operations | 3.77% | -4.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 110.93% | -- | |||
| Net Income | 11.65% | -10.19% | |||
| EBIT | 2.81% | 0.32% | |||
| EBITDA | 5.50% | 0.95% | |||
| EPS Basic | 11.62% | -10.23% | |||
| Normalized Basic EPS | 2.38% | 1.61% | |||
| EPS Diluted | 11.57% | -10.19% | |||
| Normalized Diluted EPS | 2.45% | 1.55% | |||
| Average Basic Shares Outstanding | 0.04% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | -- | |||
